Sara Charmsaz

Sara Charmsaz is a seasoned professional in the field of Translational Sciences with a strong focus on oncology and biomarker discovery. Currently serving as Director of Translational Sciences at Allogene Therapeutics since July 2024, Sara previously held positions as Associate Director and Senior Scientist at Sonoma Biotherapeutics from July 2021 to July 2024. Prior to this, Sara was a Principal Investigator and Senior Scientist at the Royal College of Surgeons in Ireland, where research centered on using multi-omic data for breast cancer biomarker identification. Additional experience includes significant roles at Pfizer/RCSI SFI Project, RCSI, and QIMR Berghofer Medical Research Institute, contributing to innovative research on breast cancer, leukemia, and glioblastoma. Sara earned a Ph.D. in Oncology and Cancer Biology from The University of Queensland, complemented by degrees in Biotechnology from Griffith University.